Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis

Annals of Neurology

Volumn 70, Issue 6, 2011, Pages 964-973

  Van Es, Michael A ^a   Schelhaas, Helenius J ^b   Van Vught, Paul W J ^a   Ticozzi, Nicola ^c,d   Andersen, Peter M ^e   Groen, Ewout J N ^a   Schulte, Claudia ^f   Blauw, Hylke M ^a   Koppers, Max ^a   Diekstra, Frank P ^a   Fumoto, Katsumi ^a   Leclerc, Ashley Lyn ^c   Keagle, Pamela ^c   Bloem, Bastiaan R ^b   Scheffer, Hans ^g   Van Nuenen, Bart F L ^b   Van Blitterswijk, Marka ^a   Van Rheenen, Wouter ^a   Wills, Anne Marie ^h   Lowe, Patrick P ^c   Hu, Guo Fu ⁱ   Yu, Wenhao ^j   Kishikawa, Hiroko ⁱ   Wu, David ^j   Folkerth, Rebecca D ^j   Mariani, Claudio ^k   Goldwurm, Stefano ^k   Pezzoli, Gianni ^k   Van Damme, Philip ^l,m,n   Lemmens, Robin ^l,m,n   Dahlberg, Caroline ^e   Birve, Anna ^e   Fernández Santiago, Rubén ^a,o,p   Waibel, Stefan ^q   Klein, Christine ^r   Weber, Markus ^s   Van Der Kooi, Anneke J ^t   De Visser, Marianne ^t   Verbaan, Dagmar ^u   Van Hilten, Jacobus J ^u   Heutink, Peter ^v   Hennekam, Eric A M ^w   Cuppen, Edwin ^w,x   Berg, Daniela ^a   Brown Jr , Robert H ^c   Silani, Vincenzo ^d,y   Gasser, Thomas ^f   Ludolph, Albert C ^q   Robberecht, Wim ^l,m,n   Ophoff, Roel A ^w,z   Veldink, Jan H ^a   Pasterkamp, R Jeroen ^a   De Bakker, Paul I W ^j,w,aa   Landers, John E ^c   Van De Warrenburg, Bart P ^b   Van Den Berg, Leonard H ^a   more..

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^e UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^f UNIVERSITY OF TÜBINGEN   (Germany)

^g RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^h MASSACHUSETTS GENERAL HOSPITAL   (United States)

ⁱ HARVARD MEDICAL SCHOOL   (United States)

^j BRIGHAM AND WOMEN S HOSPITAL   (United States)

^k PARKINSON INSTITUTE   (Italy)

^l UNIVERSITY OF LEUVEN   (Belgium)

^m DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

ⁿ UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^o UNIVERSITY OF BARCELONA   (Spain)

^p UNIVERSITY OF TÜBINGEN   (Germany)

^q UNIVERSITY OF ULM   (Germany)

^r UNIVERSITY OF LÜBECK   (Germany)

^s CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^t ACADEMIC MEDICAL CENTER   (Netherlands)

^u LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^v VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^w UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^x HUBRECHT INSTITUTE   (Netherlands)

^y UNIVERSITY OF MILAN   (Italy)

^z UNIVERSITY OF CALIFORNIA   (United States)

^aa MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIN; DNA;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; COMORBIDITY; CONTROLLED STUDY; DNA SEQUENCE; EUROPE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANTEL HAENSZEL TEST; PARKINSON DISEASE; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEQUENCE ANALYSIS; UNITED STATES;

AMYOTROPHIC LATERAL SCLEROSIS; DATABASES, FACTUAL; EUROPE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; MALE; MULTICENTER STUDIES AS TOPIC; PARKINSON DISEASE; RIBONUCLEASE, PANCREATIC; UNITED STATES;

EID: 84255163614     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22611     Document Type: Review

References (50)

1. Bensimon G, Lacomblez L, Meininger V,. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N Engl J Med 1994; 330: 585-591. (Pubitemid 24065791)
2. Rowland LP, Shneider NA,. Amyotrophic lateral sclerosis. N Engl J Med 2001; 344: 1688-1700. (Pubitemid 32479968)
3. Al-Chalabi A, Fang F, Hanby MF, et al. An estimate of amyotrophic lateral sclerosis heritability using twin data. J Neurol Neurosurg Psychiatry 2010; 81: 1324-1326.
4. van Es MA, Veldink JH, Saris CG, et al. Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis. Nat Genet 2009; 41: 1083-1087.
5. Dion PA, Daoud H, Rouleau GA,. Genetics of motor neuron disorders: new insights into pathogenic mechanisms. Nat Rev Genet 2009; 10: 769-782.
6. Ticozzi N, LeClerc AL, Keagle PJ, et al. Paraoxonase gene mutations in amyotrophic lateral sclerosis. Ann Neurol 2010; 68: 102-107.
7. Yokoseki A, Shiga A, Tan CF, et al. TDP-43 mutation in familial amyotrophic lateral sclerosis. Ann Neurol 2008; 63: 538-542. (Pubitemid 351614721)
8. Johnson JO, Mandrioli J, Benatar M, et al. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron 2010; 68: 857-864.
9. Maruyama H, Morino H, Ito H, et al. Mutations of optineurin in amyotrophic lateral sclerosis. Nature 2010; 465: 223-226.
10. Lambrechts D, Storkebaum E, Morimoto M, et al. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet 2003; 34: 383-394. (Pubitemid 36935331)
11. Oosthuyse B, Moons L, Storkebaum E, et al. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet 2001; 28: 131-138. (Pubitemid 32538057)
12. Lambrechts D, Poesen K, Fernandez-Santiago R, et al. Meta-analysis of vascular endothelial growth factor variations in amyotrophic lateral sclerosis: increased susceptibility in male carriers of the -2578AA genotype. J Med Genet 2009; 46: 840-846.
13. Greenway MJ, Alexander MD, Ennis S, et al. A novel candidate region for ALS on chromosome 14q11.2. Neurology 2004; 63: 1936-1938. (Pubitemid 39532395)
14. Greenway MJ, Andersen PM, Russ C, et al. ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis. Nat Genet 2006; 38: 411-413.
15. Schymick JC, Talbot K, Traynor BJ,. Genetics of sporadic amyotrophic lateral sclerosis. Hum Mol Genet 2007; 16: R233-R242.
16. Seilhean D, Cazeneuve C, Thuries V, et al. Accumulation of TDP-43 and alpha-actin in an amyotrophic lateral sclerosis patient with the K17I ANG mutation. Acta Neuropathol 2009; 118: 561-573.
17. van Es MA, Diekstra FP, Veldink JH, et al. A case of ALS-FTD in a large FALS pedigree with a K17I ANG mutation. Neurology 2009; 72: 287-288.
18. Annesi G, Savettieri G, Pugliese P, et al. DJ-1 mutations and parkinsonism-dementia-amyotrophic lateral sclerosis complex. Ann Neurol 2005; 58: 803-807. (Pubitemid 41552561)
19. Farnikova K, Kanovsky P, Nestrasil I, et al. Coexistence of parkinsonism, dementia and upper motor neuron syndrome in four Czech patients. J Neurol Sci 2010; 296: 47-54.
20. Gilbert RM, Fahn S, Mitsumoto H, et al. Parkinsonism and motor neuron diseases: twenty-seven patients with diverse overlap syndromes. Mov Disord 2010; 25: 1868-1875.
21. Wszolek ZK, Vieregge P, Uitti RJ, et al. German-Canadian family (family A) with parkinsonism, amyotrophy, and dementia-longitudinal observations. Parkinsonism Relat Disord 1997; 3: 125-139. (Pubitemid 28058929)
22. Logroscino G, Traynor BJ, Hardiman O, et al. Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatry 2008; 79: 6-11.
23. Majoor-Krakauer D, Ottman R, Johnson WG, et al. Familial aggregation of amyotrophic lateral sclerosis, dementia, and Parkinson's disease: evidence of shared genetic susceptibility. Neurology 1994; 44: 1872-1877. (Pubitemid 24319214)
24. Quadri M, Cossu G, Saddi V, et al. Broadening the phenotype of TARDBP mutations: the TARDBP Ala382Thr mutation and Parkinson's disease in Sardinia. Neurogenetics 2011; 12: 203-209.
25. Ross OA, Rutherford NJ, Baker M, et al. Ataxin-2 repeat-length variation and neurodegeneration. Hum Mol Genet 2011; 20: 3207-3212.
26. Payami H, Nutt J, Gancher S, et al. SCA2 may present as levodopa-responsive parkinsonism. Mov Disord 2003; 18: 425-429. (Pubitemid 36527284)
27. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-2012. (Pubitemid 30214957)
28. Conforti FL, Sprovieri T, Mazzei R, et al. A novel angiogenin gene mutation in a sporadic patient with amyotrophic lateral sclerosis from southern Italy. Neuromuscul Disord 2008; 18: 68-70. (Pubitemid 351173834)
29. Corrado L, Battistini S, Penco S, et al. Variations in the coding and regulatory sequences of the angiogenin (ANG) gene are not associated to ALS (amyotrophic lateral sclerosis) in the Italian population. J Neurol Sci 2007; 258: 123-127. (Pubitemid 46876738)
30. Del BR, Scarlato M, Ghezzi S, et al. Absence of angiogenic genes modification in Italian ALS patients. Neurobiol Aging 2008; 29: 314-316.
31. Fernandez-Santiago R, Hoenig S, Lichtner P, et al. Identification of novel angiogenin (ANG) gene missense variants in German patients with amyotrophic lateral sclerosis. J Neurol 2009; 256: 1337-1342.
32. Gellera C, Colombrita C, Ticozzi N, et al. Identification of new ANG gene mutations in a large cohort of Italian patients with amyotrophic lateral sclerosis. Neurogenetics 2008; 9: 33-40.
33. Paubel A, Violette J, Amy M, et al. Mutations of the ANG gene in French patients with sporadic amyotrophic lateral sclerosis. Arch Neurol 2008; 65: 1333-1336.
34. Wu D, Yu W, Kishikawa H, et al. Angiogenin loss-of-function mutations in amyotrophic lateral sclerosis. Ann Neurol 2007; 62: 609-617.
35. Donnelly P,. Progress and challenges in genome-wide association studies in humans. Nature 2008; 456: 728-731.
36. Manolio TA, Collins FS, Cox NJ, et al. Finding the missing heritability of complex diseases. Nature 2009; 461: 747-753.
37. Bansal V, Libiger O, Torkamani A, et al. Statistical analysis strategies for association studies involving rare variants. Nat Rev Genet 2010; 11: 773-785.
38. Madsen BE, Browning SR,. A groupwise association test for rare mutations using a weighted sum statistic. PLoS Genet 2009; 5: e1000384.
39. Price AL, Kryukov GV, de Bakker PI, et al. Pooled association tests for rare variants in exon-resequencing studies. Am J Hum Genet 2010; 86: 832-838.
40. Shulman JM, De Jager PL,. Evidence for a common pathway linking neurodegenerative diseases. Nat Genet 2009; 41: 1261-1262.
41. Scholz SW, Houlden H, Schulte C, et al. SNCA variants are associated with increased risk for multiple system atrophy. Ann Neurol 2009; 65: 610-614.
42. Zabetian CP, Hutter CM, Factor SA, et al. Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease. Ann Neurol 2007; 62: 137-144. (Pubitemid 47546499)
43. Sidransky E, Nalls MA, Aasly JO, et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med 2009; 361: 1651-1661.
44. Subramanian V, Crabtree B, Acharya KR,. Human angiogenin is a neuroprotective factor and amyotrophic lateral sclerosis associated angiogenin variants affect neurite extension/pathfinding and survival of motor neurons. Hum Mol Genet 2008; 17: 130-149.
45. Kieran D, Sebastia J, Greenway MJ, et al. Control of motoneuron survival by angiogenin. J Neurosci 2008; 28: 14056-14061.
46. Sebastia J, Kieran D, Breen B, et al. Angiogenin protects motoneurons against hypoxic injury. Cell Death Differ 2009; 16: 1238-1247.
47. Subramanian V, Feng Y,. A new role for angiogenin in neurite growth and pathfinding: implications for amyotrophic lateral sclerosis. Hum Mol Genet 2007; 16: 1445-1453. (Pubitemid 47055116)
48. Singleton AB, Farrer M, Johnson J, et al. alpha-Synuclein locus triplication causes Parkinson's disease. Science 2003; 302: 841. (Pubitemid 37339619)
49. Yacoubian TA, Cantuti-Castelvetri I, Bouzou B, et al. Transcriptional dysregulation in a transgenic model of Parkinson disease. Neurobiol Dis 2008; 29: 515-528.
50. Steidinger TU, Standaert DG, Yacoubian TA,. A neuroprotective role for angiogenin in models of Parkinson's disease. J Neurochem 2011; 116: 334-341.